ArticleEClinicalMedicine2024

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.

Ilias I Siempos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.